Successful treatment of infantile hepatitis B with lamivudine: A case report

BACKGROUND: How to treat infantile hepatitis B virus (HBV) infection remains a controversial issue. The nucleoside analogue lamivudine (LAM) has been approved to treat children (2 to 17 years old) with chronic hepatitis B. Here, we aimed to investigate the benefit of LAM treatment in infantile hepat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yu-Ting, Liu, Jing, Pan, Xiao-Ben, Gao, Yi-Dan, Hu, Yin-Fei, Lin, Li, Cheng, Hua-Jun, Chen, Gong-Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107904/
https://www.ncbi.nlm.nih.gov/pubmed/34002156
http://dx.doi.org/10.12998/wjcc.v9.i14.3442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107904/
https://www.ncbi.nlm.nih.gov/pubmed/34002156
http://dx.doi.org/10.12998/wjcc.v9.i14.3442

Ejemplares similares